Paper
31 January 1996 Chemical induction of skin tumors in hairless (Skh-1) mice in view of photochemotherapy
Edwidge Bossu, Robert Michel Parache, Dominique Notter, C. Vigneron, Francois H. Guillemin
Author Affiliations +
Abstract
The effects of a classic two-stage carcinogenesis protocol on the formation of skin tumors in hairless female SKH-1 mice were studied in order to carry out photochemotherapy on the mice bearing tumors later. Mice were initiated with a single application of 100 nmol of 7,12- dimethylbenz[a]anthracene in 0.1 ml acetone and promoted one week later, twice weekly with topical applications of 1.8 nmol (first protocol) or 5 nmol (second protocol) 12-o- tetradecanoylphorbol-13-acetate in 0.1 ml acetone. The first tumors occurred between 4 and 6 weeks after the beginning of the promotion process depending on the protocol and the percentage of mice bearing tumors increased and reached 41% and 100% at the end of the treatment respectively for the first and the second protocol. Depending on the protocol, the tumor yield was 0.8 for the first one and approximately 10 for the second one whereas we expected 3 tumors per mouse. Histology of some skin tumors revealed that all were papillomas, hence benign tumors. These papillomatous lesions seem characteristic of a viral attack as seen in other strains of mammals including humans.
© (1996) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Edwidge Bossu, Robert Michel Parache, Dominique Notter, C. Vigneron, and Francois H. Guillemin "Chemical induction of skin tumors in hairless (Skh-1) mice in view of photochemotherapy", Proc. SPIE 2625, Photochemotherapy: Photodynamic Therapy and Other Modalities, (31 January 1996); https://doi.org/10.1117/12.230947
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Skin

Astatine

Cancer

Laser therapeutics

Chemical analysis

Chemical reactions

Back to Top